Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

The Effects of Polygala Tenuifolia DM Fraction on CT105-injuried Neuronal Cells

원지 디클로로메탄분획이 CT105에 의한 신경세포 상해에 미치는 영향

  • Lee Sang Won (Department of Oriental Neuropsychiatry Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kim Sang Ho (Department of Oriental Neuropsychiatry Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kim Tae Heon (Department of Oriental Neuropsychiatry Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kang Hyung Won (Department of Oriental Neuropsychiatry Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lyu Yeoung Su (Department of Oriental Neuropsychiatry Medicine, College of Oriental Medicine, Wonkwang University)
  • 이상원 (원광대학교 한의과 대학 한방신경정신과 교실) ;
  • 김상호 (원광대학교 한의과 대학 한방신경정신과 교실) ;
  • 김태헌 (원광대학교 한의과 대학 한방신경정신과 교실) ;
  • 강형원 (원광대학교 한의과 대학 한방신경정신과 교실) ;
  • 류영수 (원광대학교 한의과 대학 한방신경정신과 교실)
  • Published : 2004.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Alzheimer's disease(AD) is a geriatric dementia that is widespread in old age. In the near future AD will be the commom disease in public health service. Although a variety of oriental presciptions in study POD(Polygala tenuifolia extracted from dichlorometan) have been traditionally utilized for the treatment of AD, their pharmacological effects and action mechanisms have not yet fully elucidated. It has been widely believed that AP peptide divided from APP causes apoptotic neurotoxicity in AD brain. However, recent evidence suggests that CT105, carboxy terminal 105 aminoacids peptide fragment of APP, may be an important factor causing neurotoxicity in AD. SK-N-SH cells expressed with CT105 exhibited remarkable apoptotic cell damage. Based on morphological observations by phase contrast microscope and NO formation in the culture media, the CT105-induced cell death was significantly inhibited by POD. In addition, AD is one of brain degeneration disease. So We studied on herbal medicine that have a relation of brain degeneration. From old times, In Oriental Medicine, PO water extract has been used for disease in relation to brain degeneration. We were examined by ROS formation, neurite outgrowth assay and DPPH scravage assay. Additionally, we investigated the association between the CT105 and neurite degeneration caused by CT105-induced apoptotic response in neurone cells. We studied on the regeneratory and inhibitory effects of anti-Alzheimer disease in pCT105-induced neuroblastoma cell lines by POD. Findings from our experiments have shown that POD inhibits the synthesis or activities of CT105, which has neurotoxityies and apoptotic activities in cell line. In addition, treatment of POD(>50 ㎍/㎖ for 12 hours) partially prevented CT(105)-induced cytotoxicity in SK-N-SH cell lines, and were inhibited by the treatment with its. POD(>50 ㎍/㎖ for 12 hours) repaired CT105-induced neurite outgrowth when SK-N-SH cell lines was transfected with CT105. As the result of this study, In POD group, the apoptosis in the nervous system is inhibited, the repair against the degerneration of Neuroblastoma cells by CT105 expression is promoted. Decrease of memory induced by injection of scopolamin into rat was also attenuted by POD, based on passive avoidance test. Taken together, POD exhibited inhibition of CT105-induced apoptotic cell death. POD was found to reduce the activity of AchE and induced about the CA1 in rat hippocampus. Base on these findings, POD may be beneficial for the treatment of AD.

Keywords

References

  1. 대한한방내과 학회지 v.16 no.1 치매에 관한 동서의학적 비교 고찰 이동원(외)
  2. 景岳全書 張介賓
  3. 辨證錄 陳士鐸
  4. 大韓韓方內科學會誌 v.13 no.2 老人性 痴 에 대한 文獻的 考察 金賢兒
  5. 東醫神經精神科學會誌 v.7 no.1 치매에 對한 文獻的 考察 鄭仁哲;李相龍
  6. 東醫神經精神科學會誌 v.7 no.1 치매에 對한 文獻的 考察 鄭仁哲(外)
  7. 동의병리학회지 v.13 no.1 치매의 병리에 대한 동ㆍ서의학적 고찰 강형원(외)
  8. ICD-10 정신 및 행동장애 분류 李符永(譯)
  9. 동의정신의학 김지혁;황의완
  10. J Neurogenet v.12 no.1 Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer`s disease brain Reznik-Wolf H.;Machado J.;Haroutuian V.;DeMacro L.;Walter G. F.;Goldman B.;Davidson M.;Johnston J. A.;Lannfelt L.;Dani S. U.;Friedman E. https://doi.org/10.3109/01677069809108555
  11. Nat Genet v.11 no.2 The structure of the presenilin 1 (SI82) gene and identification of six novel mutation in early onset AD families Alzheimer's disease collaborative group https://doi.org/10.1038/ng1095-219
  12. Alzheimer's Disease In Pharmacotherapy; a pathophysiologic approach Andrea Eggert;M. Lynn Crismon;Larry Ereshefsky;Dipiro J. T.(et al. Ed.)
  13. Neurobiol Aging v.13 no.5 Lack of Alzheimer pathology after beta-amyloid protein injection in rat brain Games D;Khan KM;Soriano FG;Keim PS;Davis DL;Bryant K;Lieberburg I https://doi.org/10.1016/0197-4580(92)90057-5
  14. Am J Pathol v.142 no.1 Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity Podlisny MB;Stephenson DT;Frosch MP;Tolan DR;Lieberburg I;Clemens JA;Selkoe DJ
  15. Neurobiol Aging v.13 no.5 Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain Clemens JA;Stephenson DT https://doi.org/10.1016/0197-4580(92)90059-7
  16. 서울대 대학원 학위논문(석사) 아밀로이드 C단 단백질 투여에 의한 생쥐의 인지 기능과 대뇌피질 및 해마의 아세틸콜린의 변화에 대한 연구 최세훈
  17. 서울대 대학원 학위논문(석사) 아밀로이드 C단 단백질에 의한 신경교세포의 활성과 염증반응에 관한 신경독성연구 라종철
  18. Neuroreport v.1;9 no.17 C-terminal fragment of amyloid precursor protein inhibits calcium uptake into rat brain microsomes by Mg2+-Ca2+ ATPase Kim HS;Park CH;Suh YH
  19. FASEB J. v.14 no.11 Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity Kim HS;Park CH;Cha SH;Lee JH;Lee S;Kim Y;Rah JC;Jeong SJ;Suh YH https://doi.org/10.1096/fj.14.11.1508
  20. Biol Psychiatry v.1;49 no.3 Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity Seo J;Kim S;Kim H;Park CH;Jeong S;Lee J;Choi SH;Chang K;Rah J;Koo J;Kim E;Suh
  21. J. Neural Transm Suppl v.58 Roles of A beta and carboxyl terminal peptide fragments of amyloid precursor protein in Alzheimer disease Suh YH;Kim HS;Lee JP;Park CH;Jeong SJ;Kim SS;Rah JC;Seo JH;Kim S
  22. 동의생리병리학회지 v.17 no.4 원지와 석창포의 혼합추출액의 pCT105로 유도된 신경세포암 세포주에 대한 항치매 효과 이성률;강형원;김상태;류영수
  23. 동의신경정신과학회지 v.13 no.2 pCT105로 유도된 치매모델에서 석창포 수추출액이 미치는 영향 최혁;김상호;이대용;안대종;강형원;류영수
  24. 本草學 全國韓醫科大學 本草學敎材共(編著)
  25. 本草品彙精要 劉文泰(等纂)
  26. 東醫神經精神科學會誌 v.10 no.1 遠志에 의한 腦 星狀細胞로부터 炎症性 細胞活性物質 分泌의 抑制 效果에 關한 硏究 황시영;강형원;유영수
  27. 成均館大學校 大學院 博士學位論文 遠志 Saponin의 利尿效果 및 中樞抑制 作用에 關한 硏究 朴大圭
  28. Neuroscience Letters v.292 A novel acethylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells Zhang HY;Tang XC;Huperzine B https://doi.org/10.1016/S0304-3940(00)01433-6
  29. Biosci. Biotech. Biochem. v.58 no.10 A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish Takao, T.;F. Kitatani;N. Watanabe;A. Yagi and K. Sakata https://doi.org/10.1271/bbb.58.1780
  30. Neuropathol Appl Neurobiol. Jun v.27 no.3 Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques. Mann DM;Takeuchi A;Sato S;Cairns NJ;Lantos PL;Rossor MN;Haltia M;Kalimo H;Iwatsubo T. https://doi.org/10.1046/j.1365-2990.2001.00316.x
  31. Am J Hum Genet. v.7 The Amyloid Precursor Protein Locus and Very-Late-Onset Alzheimer Disease. Olson JM;Goddard KA;Dudek DM
  32. Bioessays. v.23 no.8 Presenilin mutations and calcium signaling defects in the nervous and immune systems. Mattson MP;Chan SL;Camandola S https://doi.org/10.1002/bies.1103
  33. J Neurol Sci v.15 no.188(1;2) Human wild presenilin-1 mimics the effect of the mutant presenilin-1 on the processing of Alzheimer's amyloid precursor protein in PC12D cells Kametani F;Tanaka K;Usami M;Maruyama K;Mori H
  34. J Biol Chem v.268 no.31 Activation of protein kinase C inhibits cellular production of the amyloid beta-protein Hung A. Y.;Haass C.;Nitsch R. M.;Qiu W. Q.;Citron M.;Wurtman R. J.;Growdan J. H.;Selkoe D. J.
  35. J Neurosci v.16 no.14 Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer`s disease Gomez-Isla T.;Price J. L.;McKeel D. W.;Jr, Growdon J. H.;Hyman B. T. https://doi.org/10.1523/JNEUROSCI.16-14-04491.1996
  36. J. Neurochem v.65 no.4 Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease Checler F https://doi.org/10.1046/j.1471-4159.1995.65041431.x
  37. J. Neurochem v.64 no.5 Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor Barger SW;Fiscus RR;Ruth P;Hofmann F;Mattson MP https://doi.org/10.1046/j.1471-4159.1995.64052087.x
  38. Science v.2 no.258(5079) Production of the Alzheimer amyloid beta protein by normal proteolytic processing Shoji M;Glode TE;Ghiso J;Cheung TT;Estus S;Shaffer LM;Cai XD;McKay DM;Tintner R;Frangione B(et al)
  39. Proc Natl Acad Sci v.15 no.89(4) Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels Tamaoka A;Kalaria RN;Lieberburg I;Selkoe DJ
  40. Nature v.24 no.359(6393) Amyloid beta-peptides is produced by cultured cells during normal metabolism Haass C;Schlossmacher MG;Hung AY;Vigo-Pelfrey C;Mellon A;Ostaszewski BL;Lieberburg I;Koo EH;Schenk D;Teplow DB(et al)
  41. Eur J Biochem v.225 Familial Alzheimer's disease cells abnormal abnormally accumulate beta-amyloid harbouring peptides preferentially in cytosol but not in extracelluar fluid Matsmoto A and Matsumoto R https://doi.org/10.1111/j.1432-1033.1994.1055b.x
  42. Proc Natl Acad Sci v.1 no.90(9) Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration Iverfeldt K;Walaas SI;Greengard P
  43. Proc Natl Acad Sci v.85 no.19 Beta-amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane-associated proteins in neural and nonneural tissues Selkoe DJ;Podlisny MB;Joachim CL;Vickers EA;Lee g; Fritz LC; Oltersdorf T https://doi.org/10.1073/pnas.85.19.7341
  44. EMBO J v.7 no.4 Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease Dyrks T;Weidemann A;Multhaup G;Salbaum JM;Lemaire HG;Kang J Muller-Hill B;Masters CL;Beyreuther K
  45. Nature v.11 no.347(6293) Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid precursor Maruyama K;Terakado K;Usami M;Yoshikawa K
  46. Science v.28l245 no.4916 Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease Yankner BA;Dawes LR;Fisher S;Villa-Komaroff L;Oster-Granite ML;Neve RL
  47. Biochem Biophys Res Commun v.15 no.182(1) Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity Fukuchi K;Kamino K;Deeb SS;Smith AC;Dang T;Martin GM
  48. Brain Res Mol Brain Res v.26 no.1;2 Cytotoxicity mediated by conditional expression of a carboxyl- terminal derivative of the beta-amyloid precursor protein Sopher BL;Fukuchi K;Smith AC;Leppig KA; Furlong CE;Martin GM https://doi.org/10.1016/0169-328X(94)90092-2
  49. Proc Natl Acad Sci v.15 no.89(22) Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice. expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain Kammesheidt A;Boyce FM;Spanoyannis AF;Cummings BJ;Ortegon M;Cotman C;Vaught JL;Neve RL
  50. Crit Rev Neurobiol v.8 no.4 The neuropathology of the trisomy 16 mouse Lacey-Casem ML;Oster-Granite ML
  51. Neuroreport v.9 no.17 C-terminal fragment of amyloid precursor protein inhibits calcium uptake into rat brain microsomes by Mg2+-Ca2+ ATPase Kim HS;CH Park; and YH Suh https://doi.org/10.1097/00001756-199812010-00020
  52. 原色臨床本草學 辛民敎
  53. 大韓本草學會誌 v.12 no.1 遠志의 安神作用에 對한 藥理的 解析의 硏究 李熙